Cardiovascular and Hematology
Clinical Trials Experience in Indonesia
Our experience in cardiovascular and hematology trials from phase 1 to 3, including but is not limited to:
-
Hypertension
-
Dyslipidemia
-
Cholesterol
-
Thrombosis or clotting disorder
Are you ready to collaborate with us for your next cardiovascular or hematology clinical trial? Feel free to reach us out today.
Our End-to-End Services for Your Cardiovascular and Hematology Clinical Trials in Indonesia
As a leading cardiovascular and hematology CRO, our services are designed to suit with your clinical trial, this includes:
-
Feasibility Assessment and Site Network Selection
With our dedicated focus on cardiovascular disease, we have built a network of sites specializing in these studies. Equilab helps to identify and select the high performance site and Principal Investigators (PIs) for your study to ensure fast patient recruitment and study timeline targets.
-
Experienced Team for Protocol Development
Our biomedical writers design studies that align with international standards while also meeting the specific requirements of the Indonesian regulatory landscape.
-
Routine Medical Monitoring
Equilab has qualified medical monitor personnel with experience of more than 20 years to perform essential physician-led oversight and ensure the safety and well-being of every patient.
Overview
Assisting You in Developing Cardiovascular and Hematology Diseases Treatments.
Cardiovascular diseases (CVDs) are the leading cause of mortality worldwide, and Indonesia is no exception. With a substantial portion of the population affected by conditions like hypertension, which is a primary driver of CVD, there is a critical and growing need for advanced treatments.
With experience of more than 20 years in cardiovascular and hematology clinical research, Equilab can manage your clinical trials in Indonesia. By conducting these vital studies, we help develop innovative drugs and improve patient access to cutting-edge care.